Mucosal Tolerance to Experimental Autoimmune Myasthenia Gravis Is Associated with Down-regulation of AChR-specific IFN-γ-expressing Th1-like Cells and Up-regulation of TGF-β mRNA in Mononuclear Cells-Reference-Cited by-同舟云学术

Mucosal Tolerance to Experimental Autoimmune Myasthenia Gravis Is Associated with Down-regulation of AChR-specific IFN-γ-expressing Th1-like Cells and Up-regulation of TGF-β mRNA in Mononuclear Cells

Published:1996-02 Issue:1 Volume:778 Page:273-287
ISSN:0077-8923
Container-title:Annals of the New York Academy of Sciences
language:en
Short-container-title:

Author:

MA CUN-GEN,ZHANG GUANG-XIAN,XIAO BAO-GUO,WANG ZENG-YU,LINK JOANNE,OLSSON TOMAS,LINK HANS

Publisher

Wiley

Subject

History and Philosophy of Science,General Biochemistry, Genetics and Molecular Biology,General Neuroscience

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1749-6632.1996.tb21135.x/fullpdf

Reference30 articles.

1. Myasthenia gravis;Lindstrom;Adv. Immunol.,1988

2. Myasthenia gravis;Drachman;N. Engl. J. Med.,1994

3. Myasthenia gravis: stimulation of antireceptor autoantibodies by autoreactive T cell lines;Hohlfeld;Neurology,1986

4. Immunosuppressive therapy of autoimmune diseases;Bach;Immunol. Today,1993

5. Strategies for the treatment of myasthenia gravis;Drachman;Ann. N.Y. Acad. Sci.,1988

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing the potential of the NALT and BALT as targets for immunomodulation using engineering strategies to enhance mucosal uptake;Frontiers in Immunology;2024-09-02

2. Down-regulation of T cell responses to AChR and reversal of EAMG manifestations in mice by a dual altered peptide ligand via induction of CD4+CD25+ regulatory cells;Journal of Neuroimmunology;2006-08

3. Therapeutic potential of oral tolerance;Nature Reviews Immunology;2004-06

4. Induction of oral tolerance in experimental antiphospholipid syndrome by feeding with polyclonal immunoglobulins;European Journal of Immunology;2002-12

5. Rat models as tool to develop new immunotherapies;Immunological Reviews;2001-12